Arginine vasopressin, argipressin, or AVP is a peptide prohormone synthesized in the neurons of the hypothalamus. It has a primary function in maintaining body fluid balance, as well as a possible role in blood pressure regulation.
The primary function of body fluid balance
Arginine vasopressin, or ADH, is a hormone produced by the hypothalamus and posterior pituitary that controls the amount of water reabsorption by the kidneys. It also helps maintain water homeostasis in the body by controlling osmolality. It is also involved in blood pressure regulation. However, its primary function in body fluid balance remains unknown.
ADH also stimulates the production of several other hormones, including aldosterone. This steroid hormone plays a crucial role in maintaining proper water balance by enhancing Na+ reabsorption. In addition, it increases K+ secretion from the extracellular fluid. It may also contribute to salt-sensitive hypertension.
The action of vasopressin on the kidney is mediated by three receptors. The V1a receptor (V1aR) is expressed in the kidney collecting duct and interstitial cells of the medulla. Its effects are mediated by calcium and cyclic AMP signals. It induces an increase in blood flow in the descending vasa recta and stimulates the secretion of prostaglandins. A higher concentration of vasopressin is required to stimulate V1aR in the kidney.
The V2 receptor (V2R) is commonly associated with smooth muscle cells in the kidney collecting duct and endothelium. It is expressed in the kidney and has an exquisitely sensitive effect. Its effects are mediated by cyclic AMP and NO. Its effect on urea reabsorption requires a higher concentration of vasopressin. The latter is responsible for the increased permeability of the terminal inner medullary collecting duct to urea.
Vasopressin’s action is reversible and can be reversed quickly. It is cleared from the blood by the kidneys. Its action stimulates Na-K-2Cl cotransporter NKCC2 and increases the permeability of urea-rich vesicles in the luminal membrane of CD cells. It also stimulates insulin and glutamine secretion.
As a whole, vasopressin’s main effect is to help the kidneys adapt their water excretion to body needs. The secretion of this peptide is triggered by thirst and other physiological situations. It also regulates glucose and blood pressure. Despite its importance, the role of vasopressin in metabolic disorders is still unclear. A few experimental studies in animal models have been conducted to examine their role in these disorders.
Vasopressin is a polypeptide hormone containing nine amino acids in a ring structure. It is synthesized in the hypothalamus and released into the bloodstream by the pituitary stalk.
Possible role in blood pressure regulation
Arginine vasopressin (AVP), a peptide hormone produced by the hypothalamus, plays a key role in the regulation of cardiovascular stability, osmoregulation, and body water homeostasis. It has been used clinically as a vasoconstrictor to treat circulatory shock and as a vasodilator to control blood pressure in sepsis.
In addition to its role as a cardiovascular vasopressor, vasopressin plays an important role in osmoregulation, a major contributor to hypertension. Several studies have shown that high plasma vasopressin levels are associated with metabolic syndrome.
Arginine-vasopressin acts through three different receptors. These are the V1a receptor, V2 receptor, and V3 receptor. The V1a receptor is found in the kidney, where it is a target for adrenocorticotropin release. The V2 receptor is located in renal tubules, where it is a receptor for adenylyl cyclase. The V3 receptor is also found in the renal tubules, where it is associated with adrenocorticotropin and corticotropin release.
The vasopressin system is redundant with the rennin-angiotensin system in the regulation of arterial pressure. However, the relationship between the vasopressin and the rennin-angiotensin systems is not yet fully understood.
Some of the earliest evidence for the role of vasopressin in the regulation of blood pressure came from research on patients with septic shock. Landry and colleagues noted that patients with septic shock had a high sensitivity to vasopressin. These findings led to a hypothesis that the vasopressin stores were depleted in septic shock.
Another theory has suggested that impaired reflexes in spontaneously hypertensive rats may be due to vasopressin deficit in the brain stem and paraventricular nucleus. The role of vasopressin in the development of hypertension in spontaneously hypertensive rats has been controversial.
In an attempt to further elucidate the role of vasopressin in blood pressure regulation, short hypotensive stimuli were applied. The results were consistent with the role of vasopressin in regulating blood pressure in spontaneously hypertensive rats.
The relative sensitivity of the renin-angiotensin system to vasopressin has been reported to vary with different pathologic and physiological adaptations. However, a lack of data has made the role of vasopressin in the control of blood pressure a topic of debate.
Interactions with other drugs
During treatment with Vasopressin, certain drugs may decrease its effectiveness. If you have any questions, please talk to your doctor. You should not start or stop any drug without the advice of a physician.
Some of the drugs that interact with Vasopressin include chlorpropamide, neostigmine, and phenytoin. Some of these drugs increase the level of vasopressin in the body, while others may decrease it.
The effects of vasopressin are mediated by vascular V1 and V2 receptors. It acts on smooth muscle, causing contraction. In addition, it has a vasoconstrictive effect on various vascular beds. This is a type of antidiuretic effect. It also increases water reabsorption in the kidneys.
When used in vasodilatory shock, clearance of vasopressin ranges from nine to twenty-five milliliters per kilogram of body weight per minute. A larger catheter should be used for this peripheral administration.
The vasopressin dose should be adjusted for the patient’s age and renal function. In patients with decreased hepatic function or reduced renal function, the starting dose should be lower than in younger patients.
The dose should be tapered over 24 hours. If a patient feels sleepy or weak or develops any adverse reaction, tell the care provider immediately. If an overdose is suspected, call the emergency room or poison control center.
Some drugs that interact with Vasopressin include caffeine, estradiol benzoate, phenytoin, and chlorpropamide. These drugs may reduce the antidiuretic effects of vasopressin. If you are taking any of these drugs, you should avoid drinking alcohol.
Vasopressin is not recommended for use during pregnancy or lactation. It is also not approved for use in the treatment of nephrogenic diabetes insipidus.
When you are taking Vaspopressin, it is important to keep track of any changes in your blood pressure and heart rate. In addition, it is recommended to visit the physician regularly. If you experience any side effects, such as drowsiness, nausea, or abdominal pain, tell the physician right away. You should also tell the physician if you are using illegal drugs or other medicine.
Vasopressin is a peptide hormone that is produced by the hypothalamus. When the volume of blood in the body decreases, the hypothalamus releases vasopressin. The vasopressin is then released from the hypothalamus and is transmitted to the kidneys. This causes the kidneys to contract, thereby decreasing the flow of urine.
Side effects
Arginine vasopressin (AVP) is a peptide hormone secreted from the posterior pituitary gland. Its primary function is to regulate fluid and electrolyte balance. In addition, it plays a role in cardiovascular control. When arterial pressure falls below compensatory levels, AVP is released. AVP promotes the contraction of vascular smooth muscle and is able to increase blood pressure by inhibiting the local production of nitric oxide (NO).
AVP may be used to treat septic shock. This is due to the fact that there is a deficiency of vasopressin in patients with septic shock. However, the use of vasopressin has produced conflicting results in humans.
The effects of vasopressin on regional circulations are not fully understood in humans. Previously, it was thought that inadequate plasma concentrations of AVP caused hemodynamic instability. Although the role of AVP in regulating cardiac output is well-established, more recent studies have suggested the need for new indications for AVP.
The effect of AVP on arterial pressure is not as dramatic as the role of epinephrine, but it has been shown to improve renal function and decrease mortality in less severe septic shock. In a study on conscious water-deprived dogs, Reid IA found that AVP may play a role in regulating blood pressure.
In a 1977 report, Landry and colleagues reported that vasopressin increased arterial blood pressure in patients with septic shock. They also noted a rise in gastric-arterial partial carbon dioxide tension. These findings prompted the investigators to study patients with abnormally low levels of vasopressin.
In two patients, exogenous vasopressin at a dose of 0.01 U/min increased the plasma vasopressin level. This is believed to indicate a secretion defect. The authors also reported an increase in diuresis. In addition, the authors observed a collapse in arterial pressure upon discontinuation of vasopressin.
While the effects of vasopressin on global hemodynamics are well-established, the effects of vasopressin on regional blood pressure have not been firmly established. In a study on cardiac arrest patients, five patients were treated with a vasopressin infusion greater than 0.05 U/min. The authors concluded that these supraphysiological doses of vasopressin can act as platelet-aggregating agents. Nevertheless, coagulation problems make these effects undesirable.
Health Sources:
Health A to Z. (n.d.). HSE.ie. https://www2.hse.ie/az/
U.S. National Library of Medicine. (n.d.). https://www.ncbi.nlm.nih.gov/
Directory Health Topics. (n.d.). https://www.healthline.com/directory/topics
Health A-Z. (2022, April 26). Verywell Health. https://www.verywellhealth.com/health-a-z-4014770
Harvard Health. (2015, November 17). Health A to Z. https://www.health.harvard.edu/health-a-to-z
Health Conditions A-Z Sitemap. (n.d.). EverydayHealth.com. https://www.everydayhealth.com/conditions/
